Events & Presentations

Upcoming Events

Date Event
May 12, 2013 04:10 PM EDT
Tel-Aviv, Israel

Speaker(s):

  • Ori Shilo , Deputy CEO, Finance & Operations

Auditorium No. 2

June 3, 2013 10:30 AM EDT
The Grand Hyatt Hotel, New York City

Speaker(s):

  • Guy Goldberg, Chief Business Officer
July 10, 2013
St. Regis Hotel, New-York
New-York, AL
United States

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill presentation will take place July 10th at 12:00 p.m. EDT

October 28, 2013
The Ritz Carlton, Laguna Niguel, CA

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill presentation will take place on Monday, October 28, 2013, at 12:15 p.m. EDT

November 4, 2013
Vienna, Austria

RedHill's presentation will take place on Tuesday, November 5, 2013, at 8:45 a.m.
CET at the Messe Wien Exhibition and Congress Center in Vienna, Austria

November 7, 2013
Dan Tel-Aviv Hotel
Israel

Speaker(s):

  • Guest of Honor, Prof. Thomas Borody, MD.

An internationally renowned expert in the field of gastroenterology and inventor of therapeutic candidates, RHB-104 for Crohn's disease and RHB-105 for the treatment of H. pylori

RedHill Biopharma will presnet its recent clinical developments and business updates.

Registration is required, the number of participants is limited.
In order to register for please contact Merav Shiryan, no later than Oct. 15th.

January 13, 2014
Parc 55 Wyndham Hotel San Francisco – Union Square
San Francisco, CA 94102
United States
May 1, 2014 08:30 AM EDT
Tel-Aviv Stock Exchange
Israel

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill will be the second in order to present at the conference. For more information on the conference please contact:
Eran Gabay - VP and Managing Director, Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
+972 (0)3 6070 597
erang@gk-biz.com

May 11, 2014
David Intercontinental Hotel
Tel-Aviv
Israel

Speaker(s):

  • Guy Goldberg, Chief Business Officer
June 5, 2014
The Grand Hyatt, New York City

Speaker(s):

  • Guy Goldberg, Chief Business Officer

RedHill will present on Thursday, June 5, 2014, at 13:30 EDT in Ballroom 2

June 17, 2014
The InterContinental Boston - Boston, MA

Speaker(s):

  • Guy Goldberg, Chief Business Officer
June 23, 2014
San Diego, CA

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill will present on Thursday, May 26th at 10:45 am, at the Mission Beach room

September 4, 2014 08:30 AM EDT
Hilton Tel-Aviv

For more information on the conference please contact:
Eran Gabay - VP and Managing Director, Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
+972 (0)3 6070 597
erang@gk-biz.com

September 8, 2014
New-York Palace Hotel, NYC

Speaker(s):

  • Dror Ben-Asher, RedHill CEO

RedHill will present on Wendsday, September 10th, at 1:40 pm (ET), at the Holmes II Salon (4th floor)

September 22, 2014
Boston, MA, USA

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill will present on Tuesday, September 23rd, at 2:45 pm (ET), at the Suffolk room (level 3).

September 30, 2014
Congress Center Basel, Switzerland

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill will present on September 30th at 12:00 p.m. in the Darwin room.

RedHill will also take part in the Israel Panel which will take place September 30th at 14:45 p.m.

November 3, 2014
Portalhaus Messe Frankfurt, Germany

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill will present on November 4, at 10:00 am in the Transparenz room (Level 1).

November 24, 2014
Dan Hotel Tel-Aviv, Israel

RedHill is a Silver Sponsor of the Israeli IBD Society Meeting and will take part in the conference.

December 10, 2014 08:30 AM EST
Tel-Aviv Stock Exchange, Ahuzat Bayit St. 4, Isreal

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill will be the second in order to present at the conference.
For more information on the conference please contact:
Eran Gabay - VP and Managing Director, Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
+972 (0)3 6070 597
erang@gk-biz.com

November 2, 2015
Munich, Germany

Speaker(s):

  • Adi Frish, Senior VP Business Development & Licensing

RedHill's presentation will be held on Tuesday, November 3, 2015 at 10:45 am

November 18, 2015 02:40 AM UTC
The May Fair Hotel, Stratton Street, London

Speaker(s):

  • Dror Ben-Asher, CEO
January 19, 2016 08:30 AM IST
Tel-Aviv Stock Exchange, Israel

Speaker(s):

  • Dror Ben-Asher, CEO

To participate in the conference please contact Gelbat-Kahana by email at: erang@gk-biz.com, or by telephone: +972-(0)3-6070-591.

February 8, 2016
Waldorf Astoria, New York

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill will present on Tuesday, Feb.. 9th, at 4:00 pm, at the Park North room.

March 4, 2016
Stockholm, Sweden

Speaker(s):

  • Adi Frish, SVP Business Development & Licensing

RedHill's presentation will be held on Tuesday, March 5, at 10:00 am.

March 13, 2016
Orange County
CA
United States

Speaker(s):

  • Guy Goldberg, Chief Business Officer

RedHill's presentation will be held on Tuesday, March 15, 2016, at 8:30 am PT

April 5, 2016
Stockholm, Sweden

Speaker(s):

  • Adi Frish, Senior VP Business Development & Licensing

RedHill's presentation will be held on Tuesday, April 5th, at 10:00 am

April 20, 2016 08:30 AM
J.W. Marriott Essex House, New York City

Speaker(s):

  • Reza Fathi, SVP R&D

Dr. Fathi will participate in a panel discussion entitled “The Human Microbiome and Applications in Novel Therapeutics”

June 8, 2016
RedHill Biopharma Offices
Tel-Aviv
Israel

Notice is hereby given that the annual general meeting of shareholders of the Company will be held on Wednesday, June 8th, 2016 at 3:00 p.m. Israel time, at the Company’s offices located at 21 Ha'arba'a Street, Floor 16, Tel Aviv.

Please see attached file for the meeting agenda.

רדהיל מודיעה בזאת על זימונה של אסיפה כללית שנתית של בעלי המניות בחברה שתתקיים ביום
רביעי, 8 ביוני 2016, בשעה 15:00 (שעון ישראל) במשרדי החברה אשר ברחוב הארבעה 21, קומה 16,
תל אביב (טל': 03-5413131).
ראה מסמך מצורף בנוגע לסדר היום של האסיפה.

June 21, 2016
NYC

Speaker(s):

  • Dror Ben-Asher, CEO

Mr. Ben-Asher will present on Wednesday, June 21, at 10:30 am EDT.

July 26, 2016 09:00 AM EDT

RedHill will host a conference call on Tuesday, July 26, 2016, at 9:00 am EDT (4:00 pm Israel) to review the financial results and business highlights.

To participate in the conference call, please dial the following numbers five to ten minutes prior to the start of the call: United States: + +1-877-280-1254; International: + 1-646-254-3388; and Israel: +972-3-763-0147. The access code for the call is 539724.

The conference call will be broadcasted live and available for replay on the Company's website for 30 days. Please access the Company's website at least 15 minutes ahead of the conference to register, download, and install any necessary audio software.

September 12, 2016 03:00 PM EDT
The Lotte New York Palace Hotel, New York

Speaker(s):

  • Guy Goldberg, Chief Business Officer

RedHill Biopharma's presentation:

Date: 12 Sep 2016
Time: 3:00:00 PM
Room: Holmes I (4th Floor)

September 14, 2016 03:00 PM EDT
Boston Marriott Copley Place, Boston, MA

Speaker(s):

  • Adi Frish, SVP Business Development & Licensing

RedHill Biopharma's presentation:

Date: 14 Sep 2016
Time: 3:00:00 PM
Room: Salon D, Level 4

October 5, 2016
The Ritz-Carlton, Laguna Niguel, CA

Speaker(s):

  • Adi Frish, Senior VP Business Development & Licensing

RedHill Biopharma's presentation:

Date: Thursday, 6 Oct 2016
Time: 9:15 AM
Room: Ballroom, Salon 3

October 6, 2016 08:30 AM EDT

RedHill will hosted an interactive webcast and conference call on Thursday October 6th, 2016, at 8:30 a.m. EDT, to discuss the progress update on the RHB-104 Phase III Crohn’s disease program.

The webcast and accompanying presentation will be archived and available for replay on the Company's website for 30 days.

October 18, 2016 10:30 AM PDT
Westin St. Francis Hotel, San Francisco, CA

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill Biopharma's presentation:

Date: Tuesday, 18 Oct 2016
Time: 10:30 AM
Room: Elizabethan A

November 7, 2016
KoelnMesse - Congress Center North, Cologne, Germany

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

Date: Wednesday, 9 Nov 2016
Time: 11:15 AM
Room: Rheinsaal 4

November 14, 2016 09:00 AM EST

RedHill will host a conference call on Monday, November 14, 2016, at 9:00 am EST (4:00 pm Israel) to review the financial results and business highlights.

To participate in the conference call, please dial the following numbers 5-10 minutes prior to the start of the call: United States: +1-877-280-2342; International: +1-646-254-3367; and Israel: +972-3-721-9510. The access code for the call is 2341628.

The conference call will be broadcasted live and available for replay on the Company's website, http://ir.redhillbio.com/events.cfm, for 30 days. Please access the Company's website at least 15 minutes ahead of the conference to register, download, and install any necessary audio software.

November 17, 2016 02:40 PM UTC
London, UK

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill Biopharma's presentation:

Date: 17 Nov 2016
Time: 14:40:00 PM

November 21, 2016 12:00 PM CET
Sheraton Frankfurt Airport Hotel and Conference Center, Frankfurt am Main, Germany

Speaker(s):

  • Guy Goldberg, Chief Business Officer

RedHill Biopharma's presentation:

Date: Monday, 21 Nov 2016
Time: 12:00 pm
Room: Oslo

December 7, 2016 09:30 AM EST
Tel-Aviv Stock Exchange, Israel

To participate in the conference please contact Gelbat-Kahana by email at: info@gk-biz.com, or by telephone: +972-(0)3-6074-717.

RedHill Biopharma's presentation will take place at 9:30 AM.

January 9, 2017
Hilton San Francisco Union Square, San Francisco, CA

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill Biopharma's presentation:
Date: Tuesday, 10 Jan 2017
Time: 09:30 AM
Room: 3 (Ballroom Level)

February 13, 2017
The Waldorf Astoria, New York

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill Biopharma's presentation:

Date: Monday, 13 Feb 2017
Time: 03:30 PM
Room: Conrad

February 23, 2017 09:00 AM EST

RedHill will host a conference call on Thursday, February 23, 2017, at 9:00 am EST (4:00 pm Israel) to review the financial results and business highlights.

To participate in the conference call, please dial the following numbers 5-10 minutes prior to the start of the call: United States: +1-877-280-1254; International: +1-646-254-3366; and Israel: +972-3-763-0145. The access code for the call is 4402478.

The conference call will be broadcasted live and available for replay on the Company's website, http://ir.redhillbio.com/events.cfm, for 30 days. Please access the Company's website at least 15 minutes ahead of the conference to register, download, and install any necessary audio software.

March 20, 2017
Barcelona, Spain

Speaker(s):

  • Adi Frish, SVP Business Development & Licensing

RedHill Biopharma's presentation:

Date: Tuesday, 21 March 2017
Time: 2:15 PM
Room: 118 on level 1

March 25, 2017
Temple University, Philadelphia, PA

Speaker(s):

  • Ira Kalfus, MD, Medical Director

RedHill Biopharma's presentation:

Date: Saturday, 25 March 2017
Time: 9:00 AM

April 7, 2017
New York City

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill Biopharma's presentation:

Date: Friday, 7 April 2017
Time: 9:00 AM
Room: 311

April 27, 2017 08:00 AM
NYC

Members of RedHill’s executive team will be joined by key opinion leaders who will discuss BEKINDA®, its indications, the current treatment landscape, potential markets and the ongoing Phase III and II studies for acute gastroenteritis and IBS-D, respectively. A question and answer panel will be held following the presentations.

A live webcast of the event, including the slide presentation, will be available vie the below link. Please access the webcast at least 15 minutes ahead of the conference to register, download, and install any necessary audio software. A replay of the webcast will be available via the below link for a period of 30 days.

Featured Key Opinion Leaders:

Robert A. Silverman, MD, MS
Lead Investigator, BEKINDA® Phase III Study
Emergency Medicine specialist at the Hofstra North Shore-LIJ Medical Center, Associate Professor at the Hofstra North Shore-LIJ School of Medicine in NY
M. Scott Harris, MD, MS, FACP, AGAF
Consultant to RedHill Biopharma
Member of the Executive Board of the Center for Diagnostics and Therapeutics of the American Gastroenterological Association, Professor of Clinical Pharmacology and Physiology at Georgetown University School, Principal, Middleburg Consultants
Jerry Rosenblatt, PhD
RedHill Biopharma Advisory Board
Managing Partner, Foster Rosenblatt

May 3, 2017

RedHill will host a conference call on Wednesday, May 3, 2017, at 9:00 am EDT to review the financial results and business highlights.

To participate in the conference call, please dial the following numbers 15 minutes prior to the start of the call: United States: +1-877-280-2342; International: +1-212-444-0896; and Israel: +972-3-763-0147. The access code for the call is 1922788.

The conference call will be broadcasted live and available for replay on the Company's website, http://ir.redhillbio.com/events.cfm, for 30 days. Please access the Company's website at least 15 minutes ahead of the conference to register, download, and install any necessary audio software.

May 11, 2017
RedHill Biopharma Offices

Notice is hereby given that the annual general meeting of shareholders of the Company will be held on Thursday, May 11, 2017 at 3:00 p.m. Israel time, at the Company’s offices located at 21 Ha'arba'a Street, Floor 16, Tel Aviv.

Please see attached file for the meeting agenda.

June 19, 2017
San Diego Convention Center, San Diego, CA

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill Biopharma's presentation:

Date: Tuesday, 20 June 2017
Time: 04:15 PM
Room: Therater 3

June 21, 2017 08:30 AM EDT
Tel-Aviv Stock Exchange, Israel

Speaker(s):

  • Dror Ben-Asher, CEO

To participate in the conference please contact Gelbat-Kahana by email at: info@gk-biz.com, or by telephone: +972-(0)3-6074-717.

RedHill Biopharma's presentation will take place at 10:30 AM.

September 10, 2017
The Lotte New York Palace, NY

Speaker(s):

  • Guy Goldberg, Chief Business Officer

RedHill Biopharma's presentation:

Date: Tuesday, 12 September 2017
Time: 09:10 AM
Room: Louis

September 10, 2017
The Lotte New York Palace, NY

RedHill Biopharma's presentation:

Date: Tuesday, 12 September 2017
Time: 09:10 AM
Room: Louis

Contact:
info@redhillbio.com
+972-3-541-3131

September 25, 2017
InterContinental New York Barclay Hotel, NY

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill Biopharma's presentation:

Date: Tuesday, 26 September 2017
Time: 09:45 AM
Room: Grand Ballroom 1

September 26, 2017
Sheraton Boston Hotel, Boston, MA

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill Biopharma's presentation:

Date: Tuesday, 26 September 2017
Time: 11:45 AM
Room: Republic A, Level 2

October 18, 2017 08:00 AM EDT
Tel Aviv Stock Exchange, Israel

Speaker(s):

  • Dror Ben-Asher, CEO

To participate in the conference please contact Gelbat-Kahana by email at: info@gk-biz.com, or by telephone: +972-(0)3-6074-717.

October 23, 2017
Ritz Carlton, Laguna Niguel, CA

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill Biopharma's presentation:

Date: Monday, 23 October 2017
Time: 12:20 PM

November 6, 2017
Berlin

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill Biopharma's presentation:

Date: Wednesday, 8 November 2017
Time: 12:15 PM
Room: M3, Level 3

November 27, 2017
Sheraton Frankfurt Airport Hotel & Conference Center, Frankfurt

Speaker(s):

  • Guy Goldberg, Chief Business Officer

RedHill Biopharma's presentation:
Date: Tuesday, 28 November 2017
Time: 11:00 AM
Room: Oslo
Contact:
info@redhillbio.com
+972-3-5413131

February 12, 2018
New York Marriott Marquis, NY

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill Biopharma's presentation:

Date: Monday, 12 February 2018
Time: 10:45 AM
Room: Ziegfeld

March 11, 2018
The Ritz-Carlton in Orange County, CA

Speaker(s):

  • Guy Goldberg, Chief Business Officer
March 11, 2018
The Ritz-Carlton in Orange County, CA

Speaker(s):

  • Guy Goldberg, Chief Business Officer
April 8, 2018
Le Meridien Beach Plaza Hotel, Monte Carlo, Monaco

Speaker(s):

  • Guy Goldberg, Chief Business Officer

RedHill Biopharma's presentation:

Date: Monday, 9 April 2018
Time: 11:05 AM
Room: Salon Atlantique

May 2, 2018 03:00 PM IDT
RedHill Biopharma Offices

The Annual General Meeting of Shareholders of RedHill Biopharma Ltd. will be held at the offices of the Company, 21 Ha'arba'a Street, Floor 16, Tel-Aviv, Israel on May 2, 2018 at 3:00 p.m. Israel time. Please see attached file for the agenda and Proxy Statement.

Contact Name: D.F. King
Contact Email: mhorthman@dfking.com
Contact Phone: T: +1-212-232-3233

May 8, 2018

To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call:

United States: +1-800-289-0438
International: +1-929-477-0353
Israel: +972-3-376-1315

Access code: 6285484

August 30, 2018 08:30 AM EDT

To participate in the conference call, please dial one of the following numbers 15 minutes prior to the start of the call: United States: +1-800-263-0877; International: +1-646-828-8143; and Israel: +972-3-721-9463. The access code for the call is: 9460445.

The conference call will be broadcast live and will be available for replay on the Company's website, http://ir.redhillbio.com/events, for 30 days. Please access the Company's website at least 15 minutes ahead of the conference call to register, download and install any necessary audio software.

October 2, 2018
Sofitel Hotel, New York City

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill Biopharma's presentation:
Date: Tuesday, October 2, 2018
Time: 10:30 AM
Room: Track 5 - Montmartre

October 22, 2018
Vienna, Austria

An abstract discussing the study’s top-line results, ‘A Phase III Randomized, Double Blind, Placebo-Controlled, Multicenter, Parallel Group Study To Assess The Efficacy And Safety Of Add-On Fixed-Dose Anti-Mycobacterial Therapy (RHB-104) In Moderately To Severely Active Crohn's Disease (MAP US)’ was presented as a late-breaking abstract today at the United European Gastroenterology Week (UEG Week 2018) by Dr. David Y. Graham, M.D., Professor of Medicine, Molecular Virology and Microbiology at Baylor College of Medicine, Houston and Lead Investigator of the MAP US study.

October 30, 2018 08:30 AM EDT

Members of RedHill’s executive team will be joined by the study’s lead investigator and key opinion leader, Professor David Y. Graham, M.D., M.A.C.G., and will discuss TALICIA®, the ERADICATE Hp2 study, H. pylori infection, the current treatment landscape and potential market. A question and answer session will be held following the presentations.

Participants who wish to ask questions during the event can do so by dialing in to the event. To participate in the conference call, please dial one of the following numbers 5-10 minutes prior to the start of the call: United States: +1-800-458-4121; International: +1-929-477-0324; and Israel: +972-3-376-1315. The access code for the call is: 5774327.

November 5, 2018
Bella Center, Copenhagen, Denmark

Speaker(s):

  • Adi Frish, Chief Corporate & Business Development Officer

RedHill's presentation:
Date: Tuesday, Nov 6, 2018
Time: 16:15 CET
Room: B3 on level 0
Category: Gastrointestinal

December 12, 2018
Mandarin Oriental, New York

RedHill's presentation:
Date: Wednesday, Dec 12, 2018
Time: 3:00 PM ET
Room: NORTH SALON I

March 17, 2019
Ritz-Carlton, Laguna Niguel, Dana Point, CA

Speaker(s):

  • Adi Frish, Chief Corporate & Business Development Officer
March 25, 2019
Messe Wien Exhibition and Congress Center, Vienna, Austria

Speaker(s):

  • Adi Frish, Chief Corporate & Business Development Officer

RedHill's presentation:
Date: Wednesday, March 27, 2019
Time: 9:45 CET
Room: Schubert 6 on level 1
Category: Gastrointestinal

April 7, 2019
JW Marriott Grosvenor House, London, UK

Speaker(s):

  • Guy Goldberg, Chief Business Officer

RedHill's presentation:
Date: Tuesday, April 9, 2019
Time: 11:30 a.m. GMT
Room: Spencer suite

April 10, 2019
Gaylord National Harbor Hotel, Oxon Hill, MD

Speaker(s):

  • Patricia Anderson, VP, Regulatory Affairs

RedHill's presentation:
Date: Friday, April 12, 2019
Time: 3:10 p.m. EDT

April 12, 2019
Millennium Broadway Hotel & Conference Center, NY

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill's Presentation:

Date: Friday, April 12, 2019

Time: 9:00:00 - 9:25 a.m. EST

Presentation Location: Room 402/403

May 7, 2019 08:30 AM EDT

Please dial one of the following numbers 15 minutes prior to the start of the call:

United States: +1-866-966-1396
International: +1-631-510-7495
Israel: +972-3-721-7998

Access code: 1777567

The conference call will be broadcast live and will be available for replay for 30 days.

June 3, 2019
Pennsylvania Convention Center, Philadelphia, PA

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill's Presentation:

Date: Monday, June 3, 2019

Time: 1:30:00 - 1:45 p.m. EST

Presentation Location: Theater 2

June 24, 2019 03:00 PM IDT
RedHill Biopharma Offices, 21 Ha'arba'a Street, Floor 16, Tel-Aviv, Israel

Please see attached file for the agenda and Proxy Statement.

Contact Name: Kingsdale Advisors
Contact Email: contactus@kingsdaleadvisors.com
Contact Phone USA: (888) 564-7333
Contact Phone Intl: +1-416-867-2272

September 9, 2019
Lotte New York Palace Hotel, NY

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill's presentation:

Date: Monday, September 9, 2019

Time: 11:40 AM ET

Room: Adams (4th floor)

September 24, 2019
Sofitel Hotel, NY

Speaker(s):

  • Guy Goldberg, Chief Business Officer

RedHill's presentation:

Date: Tuesday, September 24, 2019

Time: 1:00 PM ET

Room: Trocadero (Track 1)

November 11, 2019
Hamburg, Germany

Speaker(s):

  • Adi Frish, Senior VP Business Development and Licensing

RedHill's presentation:

Date: Tuesday, November 12, 2019

Time: 14:30 PM

Room: Hall B1 (Level 1, room 7)

November 22, 2019
New York

The event featured presentations from RedHill's management team who provided an overview of the Company's U.S. commercial strategy for launching Talicia® and Aemcolo®. RedHill’s expects to launch Aemcolo® in Q4/19 and Talicia® in Q1/20 with its expanding dedicated sales force.

For further information please contact: investors@redhillbio.com

March 23, 2020
Paris, France

Speaker(s):

  • Adi Frish, Chief Corporate & Business Development Officer

RedHill's presentation:

Date: Tuesday, March 24, 2020

Time: 11:15 AM

Room: E04

May 4, 2020 03:00 PM IDT
RedHill Biopharma Offices, 21 Ha'arba'a Street, Floor 16, Tel-Aviv, Israel

Please see attached file for the proxy statement.

Contact Name: Kingsdale Advisors
Contact Email: contactus@kingsdaleadvisors.com
Contact Phone USA: +1-866-581-1392
Contact Phone Intl: +1-416-867-2272

May 18, 2020

Speaker(s):

  • Dror Ben-Asher, CEO

RedHill's Virtual Presentation:

Date: Monday, May 18, 2020

Time: 7:30 AM ET

June 8, 2020

Speaker(s):

  • Adi Frish, Chief Corporate & Business Development Officer
June 15, 2020

Speaker(s):

  • Gilead Raday, Chief Operating Officer

RedHill's Virtual Presentation:

Date: Monday, June 15, 2020

Time: 12:40 PM ET

July 7, 2020

Speaker(s):

  • Gilead Raday, Chief Operating Officer

Panel participation:

Topic: Potential Therapeutic Strategies to Prevent and Conquer Covid-19 Panel

Date: Wednesday, July 8, 2020

Time: 10:15 a.m. EDT/4:15 p.m. CET

October 26, 2020

Speaker(s):

  • Adi Frish, Chief Corporate & Business Development Officer
August 26, 2021</